Healthcare-associated versus community-acquired infections: a new challenge for science and society.
Healthcare and community associated MRSA are meanwhile exchanged in all directions between hospitals, long-term care facilities, nursing homes, and the community. This article is focusing on the situation concerning MRSA, but the situation concerning other multidrug-resistant (MDR) pathogens such as vancomycin-resistant enterococci or MDR Gram-negative pathogens is similar. Some European countries have started national campaigns to improve the situation significantly. They require the successful cooperation between healthcare facilities, public health authorities, health insurances, quality management and patient safety organizations, educational facilities, the public, and the veterinarian sector. These activities in the society need scientific data to provide evidence for the intervention measures and support their implementation. To really support the activities in the society, intervention studies are urgently needed to provide a more robust basis for decisions to improve the situation.
Gastmeier
Petra
P
Institute of Hygiene and Environmental Medicine, Charité University Medicine Berlin, National Reference Centre for Surveillance of Nosocomial Infections, Hindenburgdamm 27, D-12203 Berlin, Germany. Petra.Gastmeier@charite.de
D000818:Animals; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D016983:Enterococcus / Q000187:drug effects; D005060:Europe; D006090:Gram-Negative Bacteria / Q000187:drug effects; D016905:Gram-Negative Bacterial Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D017053:Infection Control / Q000379:methods*; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D012307:Risk Factors; D020713:Vancomycin Resistance